Stories
LISTEN NOW: Get the Skinny on GLP-1s — Pharmacy Friends podcast
In this episode, industry experts discuss clinical evidence, drug information and appropriate patient selection for GLP1 use.
January 9, 2024A hot topic in the health care industry is GLP-1s and chronic weight management.
In this first of a two-part episode of the Pharmacy Friends podcast, “The Skinny on GLP-1s: Part 1,” our experts discuss clinical evidence, drug information and appropriate patient selection for GLP-1 use.
Hosting this episode is Maryam Tabatabai, vice president for clinical information at Prime/MRx. She is joined by Olivia Pane, a clinical pharmacist at Prime/MRx, who also is a certified diabetes care and education specialist who focuses on the management and treatment of diabetes, weight gain and other chronic conditions. Maryam also speaks with Carole Kerzic, a drug information, and pipeline clinical pharmacist at Prime/MRx, who has extensive expertise following emerging therapeutics and investigational drugs from pipeline to post-FDA approval.
“I’m looking forward to more real-world experience with these drugs, and pharmacy organizations will play a pivotal role in staying on top of emerging data and providing education and evidence-based information to not only prescribers but also patients,” Pane said.
These experts discuss the role of lifestyle modification, upcoming drug pipeline decision and even tackle how celebrities and social media influencers have impacted the availability of these medicines.
“I’m looking forward to more real-world experience with these drugs, and pharmacy organizations will play a pivotal role in staying on top of emerging data and providing education and evidence-based information to not only prescribers but also patients,” Olivia Pane, PharmD, CDCES.
Pharmacy Friends is a podcast dedicated to bringing industry experts to the same table to talk about what is happening in pharmacy today, what is coming, and most importantly, what it means to you. You can listen to the full episode “The Skinny on GLP-1s: Part 1,” on https://www.primetherapeutics.com/pharmacy-friends/.
Related news
Stories
July 22, 2024
Introducing the latest issue of our medical and pharmacy benefit management report
The summer 2024 issue of the Magellan Rx Report provides insights on the industry’s most groundbreaking managed care solutions in some of the most complex areas of health care
Stories
July 18, 2024
Specialty drug trend forecasted to drop for employer groups, clinical experts say
Introduction of Humira® and Stelara® biosimilars contribute to continued decline in the autoimmune – anti-inflammatory trend
Stories
July 16, 2024
Prime/Magellan Rx earns top score on the Disability Equality Index
For the second consecutive year, Prime Therapeutics/Magellan Rx Management received a score of 100 on the Disability Equality Index®, which benchmarks disability workplace inclusion